The DeltaScan project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 820555

In May 2018 we received the wonderful news that our DeltaScan project proposal was selected for funding by the EU.
The proposal was ranked number 1 (the highest!) out of 138 European Grant applications. Innovative companies from all markets and all European  countries could apply. All proposals were all judged by an independent European expert committee on 3 items: impact, excellence and quality & efficiency of implementation. The committee that judged the DeltaScan project wrote a.o.: “The project presents a radically new, breakthrough product that opens up a new market, with the potential for rapid European and global -scale growth. The objectives of DeltaScan are clear and pertinent. The concept is sound and the proposed methodology is excellent. It is a proposal with a Seal of Excellence…”.
The Horizon2020 funding is a very honourful international recognition and means significant financial support. Furthermore, Prolira is proud to work together with academic Consortium Partners (UMC Utrecht (NL), Charité Universitätsmedizin Berlin (G), and Universiteitsziekenhuis Leuven (B)) for the clinical application. 

Old Situation:

DeltaScan Solution:
Prolira B.V.
Padualaan 8
3584 CH Utrecht
The Netherlands
tel: +31 (0)6 2297 8972